retatrutide drug retatrutide clinical trials for weight loss: Study shows 30% body weight loss Retatrutide - LeadWest Medical

The TRIUMPH phase 3 programme is recruiting internationally, and UK sites may be involved

Results were even more impressive

Weight reduction In a Phase 2 obesity trial, the 12-mg dose reached ~24% mean weight loss at 48 weeks

For users on tirzepatide monotherapy, blood sugar related sleep disruption is usually mild and resolves as the body adapts to the new metabolic patterns, typically within 2-4 weeks of starting or increasing the dose

3.3 Weight management and body composition optimization: foundational effect for reproductive benefit Across the diverse landscape of evidence involving various comparators and time windows, weight loss and improvements in body composition emerge as the most consistent and clinically interpretable benefit findings of GLP-1RAs in PCOS, particularly within obesity- and IR-dominant phenotypes